194 related articles for article (PubMed ID: 18304869)
21. Valtrex therapy for Epstein-Barr virus reactivation and upper respiratory symptoms in elite runners.
Cox AJ; Gleeson M; Pyne DB; Saunders PU; Clancy RL; Fricker PA
Med Sci Sports Exerc; 2004 Jul; 36(7):1104-10. PubMed ID: 15235312
[TBL] [Abstract][Full Text] [Related]
22. Effect of Epstein-Barr virus replication on Langerhans cells in pathogenesis of oral hairy leukoplakia.
Walling DM; Flaitz CM; Hosein FG; Montes-Walters M; Nichols CM
J Infect Dis; 2004 May; 189(9):1656-63. PubMed ID: 15116302
[TBL] [Abstract][Full Text] [Related]
23. Human cytomegalovirus and Epstein-Barr virus in apical and marginal periodontitis: a role in pathology?
Sunde PT; Olsen I; Enersen M; Beiske K; Grinde B
J Med Virol; 2008 Jun; 80(6):1007-11. PubMed ID: 18428124
[TBL] [Abstract][Full Text] [Related]
24. [Epstein-Barr virus-associated hemophagocytic syndrome during mid-term pregnancy successfully treated with combined methylprednisolone and intravenous immunoglobulin].
Mihara H; Kato Y; Tokura Y; Hattori Y; Sato A; Kobayashi H; Imamura A; Daimaru O; Miwa H; Nitta M
Rinsho Ketsueki; 1999 Dec; 40(12):1258-64. PubMed ID: 10658479
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Epstein-Barr virus type 1 in patients with chronic periodontitis by nested-PCR.
Moghim SH; Chalabi M; Abed AM; Rezaei F; Tamizifar H
Pak J Biol Sci; 2007 Dec; 10(24):4547-50. PubMed ID: 19093530
[TBL] [Abstract][Full Text] [Related]
26. Effect of oral valaciclovir on herpetic keratitis.
Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
[TBL] [Abstract][Full Text] [Related]
27. Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers.
Hoshino Y; Katano H; Zou P; Hohman P; Marques A; Tyring SK; Follmann D; Cohen JI
J Virol; 2009 Nov; 83(22):11857-61. PubMed ID: 19740997
[TBL] [Abstract][Full Text] [Related]
28. Herpes viruses in periodontal compromised sites: comparison between HIV-positive and -negative patients.
Grande SR; Imbronito AV; Okuda OS; Lotufo RF; Magalhães MH; Nunes FD
J Clin Periodontol; 2008 Oct; 35(10):838-45. PubMed ID: 18727655
[TBL] [Abstract][Full Text] [Related]
29. EBV and CMV in chronic periodontitis: a prevalence study.
Chalabi M; Moghim S; Mogharehabed A; Najafi F; Rezaie F
Arch Virol; 2008; 153(10):1917-9. PubMed ID: 18791835
[TBL] [Abstract][Full Text] [Related]
30. Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up.
Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
In Vivo; 2007; 21(5):707-13. PubMed ID: 18019402
[TBL] [Abstract][Full Text] [Related]
31. Detection of Epstein-Barr virus (EBV) in the oral mucosa of renal transplant patients.
Braz-Silva PH; Ortega KL; Rezende NP; Nunes FD; Magalhães MH
Diagn Cytopathol; 2006 Jan; 34(1):24-8. PubMed ID: 16355381
[TBL] [Abstract][Full Text] [Related]
32. Nonnecrotizing herpetic retinopathies masquerading as severe posterior uveitis.
Bodaghi B; Rozenberg F; Cassoux N; Fardeau C; LeHoang P
Ophthalmology; 2003 Sep; 110(9):1737-43. PubMed ID: 13129871
[TBL] [Abstract][Full Text] [Related]
33. Periodontitis lesions are the main source of salivary cytomegalovirus.
Sahin S; Saygun I; Kubar A; Slots J
Oral Microbiol Immunol; 2009 Aug; 24(4):340-2. PubMed ID: 19572898
[TBL] [Abstract][Full Text] [Related]
34. Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression.
Ballout M; Germi R; Fafi-Kremer S; Guimet J; Barguès G; Seigneurin JM; Morand P
J Virol Methods; 2007 Jul; 143(1):38-44. PubMed ID: 17368820
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus load correlating with clinical manifestation and treatment response in a patient with angioimmunoblastic T-cell lymphoma.
Battegay M; Berger C; Rochlitz C; Hurwitz N; Hirsch HH; De Geyter C; Haque T; Nadal D
Antivir Ther; 2004 Jun; 9(3):453-9. PubMed ID: 15259909
[TBL] [Abstract][Full Text] [Related]
36. A virologic pilot study of valacyclovir in infectious mononucleosis.
Balfour HH; Hokanson KM; Schacherer RM; Fietzer CM; Schmeling DO; Holman CJ; Vezina HE; Brundage RC
J Clin Virol; 2007 May; 39(1):16-21. PubMed ID: 17369082
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Sack FU; Schnabel P; Schnitzler P; Katus HA; Dengler TJ
Transpl Int; 2008 Oct; 21(10):963-71. PubMed ID: 18564989
[TBL] [Abstract][Full Text] [Related]
38. EBV-1 and HCMV in aggressive periodontitis in Brazilian patients.
Watanabe SA; Correia-Silva Jde F; Horta MC; Costa JE; Gomez RS
Braz Oral Res; 2007; 21(4):336-41. PubMed ID: 18060261
[TBL] [Abstract][Full Text] [Related]
39. Human herpesvirus 7, Epstein-Barr virus and human cytomegalovirus in periodontal tissues of periodontally diseased and healthy subjects.
Rotola A; Cassai E; Farina R; Caselli E; Gentili V; Lazzarotto T; Trombelli L
J Clin Periodontol; 2008 Oct; 35(10):831-7. PubMed ID: 18691217
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus infections: prospects for treatment.
Gershburg E; Pagano JS
J Antimicrob Chemother; 2005 Aug; 56(2):277-81. PubMed ID: 16006448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
